Nothing is more important than health
This is also reflected in the figures for the health sector. At €372 billion, the healthcare market will account for around 12% of the total gross value added in Germany in 2019, growing faster than the economy as a whole. In order for this trend to continue in the future, it is essential for all those involved in the industry to actively drive forward its digitalisation and thus ensure its competitiveness. With an industry focus on the healthcare market, highly specialised consultants and a high level of digitisation expertise, Detecon successfully supports its clients from clinics, health insurance companies and the pharmaceutical industry.
The Healthcare Ecosystem
The healthcare market comprises various players who face very individual challenges in the context of digitalisation. As Detecon, we support each of them on their way into the future. Through our experience in the industry, we bring an integrated view of the ecosystem that allows us to find the optimal digitalisation strategy for you.
Our focus in Deep Dive
Based on our Big Picture, our portfolio is aligned with the various players.
Detecon understands new technologies and knows where and how they can be used profitably.
In numerous digitalisation projects, both in healthcare and in the pharmaceutical industry, Detecon has a broad pool of blueprints and use cases for the successful application of the latest technologies. In addition, our experienced consultants have repeatedly proven that they can define and implement a suitable digital strategy. This includes the expansion and redefinition of the digitalised service portfolio, the patient experience as well as the digital optimisation of production processes. Especially the expertise in cyber security ensures that risks are well assessed and minimised. Detecon attaches great importance to actively guiding and accompanying the clients in the implementation of the strategies and in the transformation.
Use cases for digitisation in the health sector
Lengthy and paper-based admission processes can be simplified and accelerated through automated primary care data transfer, online or app-based registration. This saves time and protects the environment.
During treatment, data can be automated and digitally recorded. This makes the patient history easier to manage and transfer. This promotes the completeness of the history and a decrease in the risk of treatment errors.
By virtually overlaying patient data, organs and vessels, augmented and virtual reality can empower doctors and better design surgeries. Students can benefit from streaming opportunities for learning purposes.
The prices of medicines and generics differ greatly. The political discussion on this points to misaligned incentives in our health care system, which demand new business model solutions from pharmaceutical companies, among others.
Beds and equipment are expensive purchases and are rarely available. A remedy is the digital tracking of beds or expensive equipment. This means increased efficiency in work processes and optimisation in purchasing.
Medicines can work differently depending on the person. Drug development on gene-based therapies enables individualised treatment, greater treatment success, fewer side effects and more satisfied customers.
Analyses of the insured and the use of exchange channels enable the development of new premium systems. Real-time analysis allows you to offer customers exactly the right product they need.
Self-diagnosis is the trend. The increasing number of smart devices enables extensive examination from home. In this way, diseases can be detected before they break out or become acute.
New regulations such as the EDP require networked devices that must both fit into the hospital systems and provide the right interfaces. With the right safety requirements, these are the products of the future.